Aethlon Medical Submits Avian Flu Treatment Grant (Business Wire via Yahoo! Finance)
SAN DIEGO----April 12, 2006--Aethlon Medical, Inc. , a pioneer in developing therapeutic devices for infectious disease, announced today that it has submitted an Avian Flu-related grant application entitled, "Extracorporeal Treatment of H5N1 Bird Flu Viral Sepsis."

Genentech Submits Supplemental Biologics License Application for Avastin(R) With Chemotherapy in First-Line, (FinanzNachrichten)
SOUTH SAN FRANCISCO, Calif., April 11 /PRNewswire-FirstCall/ -- Genentech, ( Nachrichten ) Inc. announced today that the company submitted a supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) for Avastin(R) (bevacizumab) in combination with platinum-based chemotherapy for first-line treatment of advanced, non- squamous, non-small cell lung cancer

American Pharmaceutical Partners Adds to Its Broad Oncology Portfolio With the Approval of Mitoxantrone Injection, USP (RedNova)
American Pharmaceutical Partners, Inc. (NASDAQ:APPX) (APP), a leading specialty injectable pharmaceutical company, today announced that it has received approval from the U.S.